CLASS I Drug recall · Reported 26 Sep 2018 · FDA Enforcement Report

Norepinephrine 4 mg (16 mcg/mL) added to 5% Dextrose Bag recalled

QuVa Pharma is recalling Norepinephrine 4 mg (16 mcg/mL) added to 5% Dextrose Bag Preservative Free, distributed nationwide in the US. The recall was initiated on 27 Aug 2018 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot #:30000271, Exp 10/1/18
Quantity recalled528 bags

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0003-2019
FDA event ID
80980
Recalling firm
QuVa Pharma, Sugar Land, TX
Classification
Class I
Status
Terminated
Recall initiated
27 Aug 2018
FDA classified
1 Oct 2018
Reported
26 Sep 2018
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Potency & Assay

Timeline

27 Aug 2018Recall initiated by company
26 Sep 2018Published in enforcement report+30 days
1 Oct 2018Classified by FDA+5 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Subpotent Drug: Product may not have the active ingredient present in the bag.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Norepinephrine 4 mg (16 mcg/mL) added to 5% Dextrose 250 mL Bag Preservative Free, Rx only, QuVa Pharma, 519 Route 173, Bloombury, NJ 08804, UPC 70092103417.

Where it was distributed

Nationwide to hospitals in USA

Nationwide

Questions about this recall

Why was it recalled?

Subpotent Drug: Product may not have the active ingredient present in the bag.

Which lots are affected?

Lot #:30000271, Exp 10/1/18

Where was it sold?

Nationwide to hospitals in USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from QuVa Pharma

All 38

Other Norepinephrine recalls

All 16